Stocks股票 / Health Care / VTRS
VTRS US listed · USD美股 · 美元
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania.威达瑞公司是一家总部位于宾夕法尼亚州卡农斯堡的美国全球制药和医疗保健企业。
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考;使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动,请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-08-14Earnings财务业绩
Estimates being cut预期下调
Valuation估值
Looks cheap vs sector相对行业偏便宜| Multiple指标 | VTRS | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/S市销率 | 1.29x | 3.20 | |
| FCF yield自由现金流收益率 | 10.49% | 4.00 | |
| Shareholder yield股东收益率 | 2.71% | 1.83 | |
| EV/EBITDA企业价值/EBITDA | 233.48x | 19.05 | |
| P/FCF市值/自由现金流 | 9.54x | 22.49 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Options positioning期权持仓
as of last close截至上一收盘Market makers are net short gamma — price moves may amplify做市商净持有负伽玛,价格波动可能被放大
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: -$1.1M net (0 buyers, 1 sellers)-$1.1M 净值(0 买家,1 卖家)
Signal history信号历史
engine events引擎事件Company profile公司档案
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania.威达瑞公司是一家总部位于宾夕法尼亚州卡农斯堡的美国全球制药和医疗保健企业。
- Capital intensity rising
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| Price / Sales市销率 | 1.3× | 3.2× | 77% |
| EV / EBITDAEV/EBITDA | 233.5× | 19.1× | 1% |
| Free-cash-flow yield自由现金流收益率 | 12.5% | 5.3% | 90% |
| Shareholder yield股东综合回报率 | 2.7% | 1.8% | 63% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -1.5% | +1.2% |
| 1 Month近1月 | -1.7% | +3.5% |
| 3 Months近3月 | -2.0% | +5.2% |
| 6 Months近6月 | +3.3% | +14.4% |
| Year to date年初至今 | +30.8% | +14.2% |
| 1 Year近1年 | +60.2% | +21.6% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $11.9B | $17.9B | $16.3B | $15.4B | $14.7B | $14.3B |
| EPS每股收益 | $-1.11 | $-1.05 | $1.71 | $0.05 | $-0.53 | $-3.00 |
| Free cash flow自由现金流 | $989M | $2.6B | $2.5B | $2.4B | $2.0B | $1.9B |
| Gross margin毛利率 | 31.8% | 31.2% | 40.0% | 41.7% | 38.2% | 35.1% |
| Net margin净利率 | -5.6% | -7.1% | 12.8% | 0.4% | -4.3% | -24.6% |
| FCF margin自由现金流利润率 | 8.3% | 14.3% | 15.7% | 15.7% | 13.4% | 13.5% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量:盈利有现金支撑
- Working capital: inventory & receivables lean vs sales营运资本:存货与应收相对销售保持精简
- Pricing power: soft gross profitability vs peers定价能力:毛利能力弱于同业
- Capital discipline: investment near the peer median资本纪律:投资力度接近同业中位
- Balance sheet: Altman Z 0.71 — distress zone资产负债表:Altman Z 0.71——困境区